AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

JASPER™ Robotic Surgical System (Formerly Known as the ORYOM™ Robotic Surgical System) in Cataract Surgery

RecruitingNAAges 55 Years - 80 YearsAllForSight Robotics Ltd
💬

In plain words

What the trial is, and whether it could suit you

This is a prospective, open-label clinical study designed to evaluate the performance and safety of the JASPER™ Robotic Surgical System during cataract surgery.

Sign in to get the eligibility rules as simple questions to take to your doctor.

📋 Eligibility rules (as published)
Main Inclusion Criteria: * Patient aged 55 to 80 years * Willing and able to sign an informed consent, attend the clinic and comply with all study procedures and the study protocol * Patients are scheduled to undergo cataract surgery * Clear intraocular media, other than cataract * Pupil dilate according to stand of care Main Exclusion Criteria: * Prior ocular surgery or trauma in the study eye * Polar cataract in the study eye * Zonular instability or significant anterior segment abnormalities * Active ocular infection or uveitis * Pseudoexfoliation (PXF) syndrome in either eye * ASA Physical Status Classification \> 3 * Participation in another clinical trial within 30 days
💊

What it tests

  • JASPER™ Robotic Surgical System
📍

Where

1 site
Asian Eye Instiitute
Makati City, Philippines
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy